Profile data is unavailable for this security.
About the company
IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The Company develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The Company is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.
- Revenue in USD (TTM)0.00
- Net income in USD-88.50m
- Incorporated2021
- Employees68.00
- LocationIO Biotech IncOle Maaloes Veh 3COPENHAGEN 2200DenmarkDNK
- Websitehttps://www.iobiotech.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Checkpoint Therapeutics Inc | 68.00k | -52.32m | 91.92m | 23.00 | -- | -- | -- | 1,351.79 | -2.37 | -2.37 | 0.0028 | -0.2872 | 0.0076 | -- | -- | 2,956.52 | -585.51 | -142.43 | -- | -342.79 | -- | -- | -76,938.23 | -6,554.97 | -- | -- | -- | -- | -46.35 | -50.61 | 17.21 | -- | -- | -- |
Aeon Biopharma Inc | 0.00 | -485.01m | 91.94m | 10.00 | -- | -- | -- | -- | -13.04 | -13.04 | 0.00 | -5.20 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -27.67 | -- | -- | -- | -- | -631.85 | -- | -- | -- |
Assembly Biosciences Inc | 12.95m | -51.36m | 92.00m | 65.00 | -- | 2.53 | -- | 7.11 | -11.22 | -11.22 | 2.76 | 5.95 | 0.1276 | -- | 34.07 | 199,200.00 | -50.60 | -39.69 | -66.58 | -44.03 | -- | -- | -396.63 | -409.24 | -- | -- | 0.00 | -- | -- | -13.51 | 34.23 | -- | -5.59 | -- |
Tiziana Life Sciences Ltd - ADR | 0.00 | -15.40m | 92.78m | 9.00 | -- | 4.70 | -- | -- | -0.1496 | -0.1496 | 0.00 | 0.1914 | 0.00 | -- | -- | 0.00 | -40.89 | -- | -50.40 | -- | -- | -- | -- | -- | -- | -2,083.71 | 0.0183 | -- | -- | -- | 34.25 | -- | -- | -- |
Hillevax Inc | 0.00 | -143.51m | 93.97m | 90.00 | -- | 0.3881 | -- | -- | -3.29 | -3.29 | 0.00 | 4.87 | 0.00 | -- | -- | 0.00 | -46.66 | -- | -50.34 | -- | -- | -- | -- | -- | -- | -- | 0.0963 | -- | -- | -- | 22.68 | -- | -- | -- |
Aclaris Therapeutics Inc | 31.12m | -77.26m | 94.78m | 91.00 | -- | 0.6673 | -- | 3.05 | -1.09 | -1.09 | 0.4392 | 1.99 | 0.1541 | -- | 58.77 | 341,967.00 | -38.27 | -47.29 | -42.29 | -53.87 | 41.99 | 44.00 | -248.28 | -549.18 | -- | -- | 0.00 | -- | 5.03 | 38.41 | -1.81 | -- | -0.703 | -- |
Sagimet Biosciences Inc | 2.00m | -27.92m | 98.61m | 10.00 | -- | 0.519 | -- | 49.31 | -1.23 | -1.23 | 0.0862 | 5.95 | 0.018 | -- | -- | 200,000.00 | -25.18 | -- | -26.34 | -- | -- | -- | -1,395.90 | -- | -- | -- | 0.00 | -- | -- | -- | 8.60 | -- | -- | -- |
Anixa Biosciences Inc | 0.00 | -11.60m | 100.18m | 4.00 | -- | 4.24 | -- | -- | -0.3694 | -0.3694 | 0.00 | 0.7381 | 0.00 | -- | -- | 0.00 | -45.19 | -59.69 | -46.33 | -62.61 | -- | -- | -- | -6,040.10 | -- | -- | 0.00 | -- | -- | -28.36 | 27.83 | -- | -- | -- |
IO Biotech Inc | 0.00 | -88.50m | 101.46m | 68.00 | -- | 0.8787 | -- | -- | -1.86 | -1.86 | 0.00 | 1.75 | 0.00 | -- | -- | 0.00 | -66.79 | -- | -72.66 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -20.47 | -- | -- | -- |
Omega Therapeutics Inc | 4.94m | -92.28m | 102.04m | 93.00 | -- | 2.47 | -- | 20.66 | -1.67 | -1.67 | 0.0896 | 0.7498 | 0.029 | -- | 6.08 | 53,107.53 | -54.28 | -- | -62.10 | -- | -- | -- | -1,868.35 | -- | -- | -- | 0.302 | -- | 49.25 | -- | 5.13 | -- | -- | -- |
Cardiff Oncology Inc | 610.00k | -40.25m | 105.10m | 31.00 | -- | 1.73 | -- | 172.30 | -0.901 | -0.901 | 0.0137 | 1.36 | 0.0068 | -- | 1.14 | 19,677.42 | -44.55 | -31.24 | -50.10 | -33.56 | -- | -- | -6,594.92 | -7,819.23 | -- | -- | 0.00 | -- | 26.42 | 5.22 | -7.07 | -- | 157.91 | -- |
Oramed Pharmaceuticals, Inc. | 674.00k | 10.46m | 105.23m | 15.00 | 10.41 | 0.6298 | 10.07 | 156.13 | 0.2488 | 0.2488 | 0.0165 | 4.11 | 0.0037 | -- | -- | 44,933.33 | 5.63 | -- | 6.27 | -- | -- | -- | 1,518.25 | -- | -- | -- | 0.162 | -- | -50.43 | -- | 115.11 | -- | -- | -- |
Vistagen Therapeutics Inc | 1.06m | -29.36m | 106.06m | 39.00 | -- | 0.927 | -- | 99.68 | -2.12 | -2.12 | 0.055 | 4.23 | 0.0147 | -- | -- | 27,282.05 | -40.57 | -62.84 | -43.48 | -68.03 | -- | -- | -2,759.59 | -5,768.52 | -- | -- | 0.00 | -- | 568.10 | -- | 50.44 | -- | -18.91 | -- |
Eledon Pharmaceuticals Inc | 0.00 | -39.85m | 106.28m | 20.00 | -- | 0.9153 | -- | -- | -1.41 | -1.41 | 0.00 | 3.02 | 0.00 | -- | -- | 0.00 | -48.86 | -38.44 | -51.95 | -39.80 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 54.16 | -- | -- | -- |
Armata Pharmaceuticals Inc | 4.70m | -79.58m | 107.38m | 66.00 | -- | -- | -- | 22.85 | -2.20 | -2.20 | 0.1302 | -1.56 | 0.041 | -- | 3.16 | 71,196.97 | -69.46 | -59.78 | -235.17 | -72.70 | -- | -- | -1,693.47 | -1,113.72 | -- | -1.11 | 1.75 | -- | -17.77 | -- | -87.03 | -- | 184.10 | -- |
Rapt Therapeutics Inc | 0.00 | -118.05m | 108.92m | 126.00 | -- | 0.8325 | -- | -- | -3.07 | -3.07 | 0.00 | 3.76 | 0.00 | -- | -- | 0.00 | -58.42 | -46.30 | -65.33 | -49.97 | -- | -- | -- | -3,522.72 | -- | -- | 0.00 | -- | -100.00 | -- | -39.31 | -- | -20.31 | -- |
Holder | Shares | % Held |
---|---|---|
Lundbeckfond Invest A/Sas of 09 Aug 2023 | 13.95m | 21.18% |
HBM Partners AG (Investment Management)as of 31 Dec 2023 | 3.94m | 5.99% |
PFM Health Sciences LPas of 31 Mar 2024 | 2.34m | 3.55% |
Marshall Wace LLPas of 31 Mar 2024 | 2.11m | 3.20% |
Morgan Stanley & Co. LLCas of 31 Mar 2024 | 2.00m | 3.04% |
Armistice Capital LLCas of 31 Mar 2024 | 1.72m | 2.62% |
BofA Securities, Inc.as of 31 Mar 2024 | 1.65m | 2.51% |
Logos Global Management LPas of 31 Mar 2024 | 493.83k | 0.75% |
Fidelity Management & Research Co. LLCas of 31 Mar 2024 | 314.60k | 0.48% |
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024 | 194.35k | 0.30% |